SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

12 Aug 2025 Evaluate
A slight decline in the revenue of Rs. 8102.08 millions was seen for the June 2025 quarter as against Rs. 8519.50 millions during year-ago period.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 694.85  millions as against Rs. 937.79 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 1567.87 millions from 1792.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 8102.08 8519.50 -4.90 8102.08 8519.50 -4.90 30301.63 37550.91 -19.31
Other Income 131.52 18.08 627.43 131.52 18.08 627.43 406.80 57.77 604.17
PBIDT 1567.87 1792.23 -12.52 1567.87 1792.23 -12.52 6054.84 8071.37 -24.98
Interest 136.73 175.17 -21.94 136.73 175.17 -21.94 627.80 719.98 -12.80
PBDT 1309.54 1617.06 -19.02 1309.54 1617.06 -19.02 5734.54 7351.39 -21.99
Depreciation 395.07 358.47 10.21 395.07 358.47 10.21 1462.30 1438.48 1.66
PBT 914.47 1258.59 -27.34 914.47 1258.59 -27.34 4272.24 5912.91 -27.75
TAX 219.62 320.80 -31.54 219.62 320.80 -31.54 1078.88 1553.73 -30.56
Deferred Tax -10.30 10.53 -197.82 -10.30 10.53 -197.82 -19.91 47.68 -141.76
PAT 694.85 937.79 -25.91 694.85 937.79 -25.91 3193.36 4359.18 -26.74
Equity 242.64 242.37 0.11 242.64 242.37 0.11 242.54 242.37 0.07
PBIDTM(%) 19.35 21.04 -8.01 19.35 21.04 -8.01 19.98 21.49 -7.04

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×